To reveal the underlying mechanism of SLC6A9 downregulation in resistant cancer cells, a continuous complementary region was identified in the PARP-1 promoter sequence when we inspected the genomic sequence of SLC6A9 (Figure 4a). The gene discussed is PARP1; the disease is cancer.